Circadian clock gene Per2 plays an important role in cell proliferation, apoptosis and cell cycle progression in human oral squamous cell carcinoma

• DOI: 10.3892/or.2016.4724
• Publication Date: 2016-04-01T07:24:28Z
• Authors: QINGQING WANG; YIRAN AO; KAI YANG; HONG TANG; DAN CHEN
• Keywords: 0301 basic medicine; Cell Cycle; Mouth Mucosa; Apoptosis; Period Circadian Proteins; Cyclin-Dependent Kinases; 3. Good health; 03 medical and health sciences; Cell Line, Tumor; Carcinoma, Squamous Cell; Humans; Mouth Neoplasms; Tumor Suppressor Protein p53; E2F1 Transcription Factor; Cell Proliferation

Previous studies have shown that the aberrant expression of period circadian clock 2 (Per2) is closely related to the occurrence and development of cancers, but the specific mechanism remains unclear. In the present study, we used shRNA to downregulate Per2 in oral squamous cell carcinoma (OSCC) Tca8113 cells, and then detected the alterations in cell cycle, cell proliferation and apoptosis by flow cytometric analysis and mRNA expression alterations in all the important genes in the cyclin/cyclin-dependent protein kinase (CDK)/cyclin-dependent kinase inhibitor (CKI) cell cycle network by RT-qPCR. We found that in the Tca8113 cells, after Per2 downregulation, the mRNA expression levels of cyclin A2, B1 and D1, CDK4, CDK6 and E2F1 were significantly increased (P<0.05), the mRNA expression levels of p53, p16 and p21 were significantly decreased (P<0.05), cell proliferation was significantly higher (P<0.05), apoptosis was significantly lower (P<0.05) and the number of cells in the G1/G0 phase was significantly decreased (P<0.05). The present study proves that in OSCC, clock gene Per2 plays an important role in cell cycle progression and the balance of cell proliferation and apoptosis by regulation of the cyclin/CDK/CKI cell cycle network. Further research on Per2 may provide a new effective molecular target for cancer treatments.